瑞舒伐他汀与阿托伐他汀治疗冠心病的疗效对比研究  

Comparative Study of Rosuvastatin and Atorvastatin in the Treatment of Coronary Heart Disease

作　　者：李静[1] 

机构地区：[1]河南省南阳市中心医院,南阳473000

出　　处：《数理医药学杂志》2017年第10期1506-1507,共2页Journal of Mathematical Medicine

摘　　要：目的:比较运用瑞舒伐他汀和阿托伐他汀针对冠心病患者展开治疗的临床效果差异。方法:244例冠心病患者随机分为研究组和参照组,每组各122例,参照组患者实施阿托伐他汀药物治疗,研究组患者实施瑞舒伐他汀药物治疗,观察比较两组患者的临床治疗效果。结果:研究组患者的临床治疗有效率明显高于参照组患者,差异有统计学意义(P<0.05);研究组患者的血清高密度蛋白胆固醇含量指标和内皮舒张生理功能指标均明显高于参照组患者,其他生理指标均低于参照组,差异有统计学意义(P<0.05)。结论:针对临床中收治的经确诊冠心病患者实施瑞舒伐他汀药物治疗,能够获取到较好临床效果,值得在临床医学实践过程中加以推广普及运用。Objective：To compare the use of rosuvastatin and atorvastatin in coronary heart patients and the difference of clinical treatment effect.Methods：244 cases of patients with coronary heart disease were randomly divided into study group and control group,122 cases in each group.The control group patients received atorvastatin therapy,the study group received rosuvastatin treatment,and then observe the clinical curative effect of two groups.Results：The total effective rate of the research group clinical treatment was significantly higher than that in the control group（P〈0.05）.The serum high density lipoprotein cholesterol content index and endothelial function index of the study group were higher than those of the control group.The other indexes were lower than those of the control group,with statistically significant difference（P〈0.05）.Conclusion：Rosuvastatin has good effect in the clinical diagnosis of coronary heart disease,which can get better clinical effect and is worth popularizing in clinical practice by medicine.

关 键 词：瑞舒伐他汀 阿托伐他汀 冠心病 

分 类 号：R541.4[医药卫生—心血管疾病]